24/07/2026
ERCP is the reference endoscopic procedure for biliary and pancreatic disease. Discover indications, techniques, complication management and the devices involved.
07/07/2026
Endoscopic retrograde cholangiopancreatography (ERCP) is one of the most technically demanding procedures in interventional gastroenterology. It combines flexible endoscopy with real-time fluoroscopic imaging to visualise, diagnose, and treat disorders affecting the biliary tract, gallbladder, and pancreatic duct system.
Cholelithiasis — the most frequent underlying condition leading to ERCP referral — affects approximately 15–20% of the adult population in Western countries. A significant proportion of these patients develop complications such as choledocholithiasis (common bile duct stones), acute cholangitis, or biliary pancreatitis, conditions that require prompt endoscopic intervention to reduce morbidity and mortality.
Driven by advances in duodenoscope technology and the expanding arsenal of accessory devices, ERCP has progressively replaced surgery as the first-line treatment for the majority of obstructive biliary pathologies. This is reflected in the ESGE Clinical Guidelines on ERCP (2019, updated 2022), which position endoscopic therapy as the standard of care across a broad spectrum of biliopancreatic indications.
ERCP is indicated in both diagnostic and therapeutic settings, although the advent of non-invasive imaging modalities — magnetic resonance cholangiopancreatography (MRCP) and endoscopic ultrasound (EUS) — has substantially reduced its purely diagnostic role.
Primary therapeutic indications:
Choledocholithiasis. The presence of stones within the common bile duct is the most common indication for ERCP. The procedure enables endoscopic sphincterotomy (division of the sphincter of Oddi) followed by stone extraction using a balloon extraction catheter or Dormia basket.
Biliary strictures. In the setting of benign strictures (post-surgical, chronic pancreatitis-related) or malignant obstruction (cholangiocarcinoma, pancreatic head carcinoma), ERCP allows the placement of plastic biliary stents or self-expanding metal stents (SEMS) to restore biliary drainage.
Acute biliary pancreatitis with cholangitis. In patients presenting with acute cholangitis secondary to biliary obstruction, international guidelines recommend urgent ERCP within 24–72 hours of symptom onset.
Pancreatic duct pathology. ERCP is employed in the management of pancreatic duct strictures, pancreatic fistulae, and intraductal stones in the context of chronic pancreatitis.
The patient must be fasted for a minimum of six hours prior to the procedure. Pre-procedural coagulation screening (INR, platelet count) is required, and anticoagulant or antiplatelet therapy must be managed according to ESGE-recommended bridging protocols.
ERCP is performed on an inpatient or day-case basis in an endoscopy suite equipped with a fluoroscopy unit and a radiolucent table. The patient is typically positioned in the prone or left lateral decubitus position.
A side-viewing duodenoscope — specifically designed to reach the major duodenal papilla (the ampulla of Vater, where the common bile duct and pancreatic duct drain into the duodenum) — is used. The instrument channel of the duodenoscope accommodates the accessory devices required throughout the procedure.
The key steps of therapeutic ERCP include:
Mechanical lithotripsy is the first-line technique for difficult choledochal stones — defined as large (>15 mm), multiple, barrel-shaped, or impacted stones that cannot be extracted by standard balloon or basket techniques.
The lithotripter basket is deployed around the stone and progressively tightened until fragmentation occurs, after which the resulting fragments are retrieved using a balloon catheter.
In cases where mechanical lithotripsy proves insufficient, intraductal laser lithotripsy (using holmium or pulsed-dye laser systems under choledochoscopic guidance via SpyGlass DS or equivalent platforms) or extracorporeal shock wave lithotripsy (ESWL) are available as second-line options at tertiary referral centres.
The technical success of an ERCP procedure is critically dependent on the quality and reliability of the accessory devices employed. The ERCP kits and single-use accessories distributed by Meditalia S.r.l. — including sphincterotomes, selective cannulation catheters, extraction balloons, Dormia baskets, hydrophilic guidewires, and biliary stents — are selected to ensure precise manoeuvrability, compatibility with the leading duodenoscopes on the market, and full compliance with EU MDR Regulation 2017/745.
The use of certified single-use accessories is strongly supported by regulatory guidance from both the FDA and European competent authorities, particularly following documented outbreaks of multidrug-resistant organism transmission associated with inadequately reprocessed reusable duodenoscopes. Single-use design eliminates this risk category entirely, offering an additional layer of patient safety in a high-complexity procedural setting.
ERCP carries the highest complication rate among standard endoscopic procedures. Careful patient selection, risk stratification, and meticulous technique are essential to minimise adverse events.
Post-ERCP pancreatitis (PEP). The most frequent complication, with an incidence of 3–5% in the general population and up to 10–15% in high-risk patients (difficult cannulation, sphincter of Oddi dysfunction, female sex, prior PEP). Rectal indomethacin (100 mg) is recommended as universal prophylaxis by all major guidelines, unless contraindicated, and has been shown to significantly reduce PEP incidence and severity.
Post-procedural cholangitis.
Less common, typically arising from incomplete biliary drainage or bacterial contamination. Management involves targeted antibiotic therapy and, in severe cases, repeat endoscopic or percutaneous transhepatic biliary drainage.
Post-sphincterotomy bleeding. Occurs in 1–2% of cases, in the majority manageable endoscopically with adrenaline injection, bipolar electrocoagulation, or haemostatic clip placement.
Perforation. Rare (0.1–0.6%), but potentially life-threatening. Requires immediate multidisciplinary assessment involving surgical consultation.
Choledochoscopy — direct intraluminal visualisation of the common bile duct using a miniaturised probe introduced through the working channel of the duodenoscope — represents the most advanced frontier of ERCP-based intervention. Systems such as SpyGlass DS II enable targeted biopsy of indeterminate biliary strictures and laser lithotripsy under direct vision, delivering a substantial improvement in diagnostic yield and therapeutic success rates compared to conventional fluoroscopy-guided techniques alone.
ERCP is a technically complex endoscopic procedure that demands appropriately equipped centres, specifically trained operators, and high-quality medical devices. When performed in the right clinical context and with the appropriate technology, it achieves excellent therapeutic outcomes, avoiding surgery in the vast majority of biliary and pancreatic conditions.
Meditalia S.r.l. supports interventional endoscopy centres with a comprehensive range of ERCP accessories — from cannulation to biliary stenting. Browse the full product catalogue at meditaliagroup.net or contact the Meditalia commercial team for dedicated technical consultation.
Endoscopic retrograde cholangiopancreatography (ERCP) is a procedure combining endoscopy and fluoroscopy to diagnose and treat disorders of the biliary tract and pancreas. Primary indications include choledocholithiasis, biliary strictures, acute cholangitis, and pancreatic duct pathology in chronic pancreatitis.
ERCP is performed under deep sedation or general anaesthesia, so the patient experiences no pain during the procedure. Mild abdominal discomfort and nausea may occur in the hours following the examination and typically resolve within 24 hours.
The most frequent complication is post-ERCP pancreatitis (3–5%), mitigated by universal prophylaxis with rectal indomethacin. Less common adverse events include cholangitis, post-sphincterotomy bleeding, and perforation. ERCP is recommended only when the clinical benefit clearly outweighs the procedural risk.
Procedure duration ranges from 30 to 90 minutes depending on complexity — straightforward cannulation, stone extraction, or stent placement. The patient remains under post-procedural observation for several hours before discharge.
In the absence of complications, oral fluid intake may resume after 4–6 hours, with a return to a solid diet the following morning. If post-ERCP pancreatitis is suspected, fasting is prolonged and the patient is kept under clinical and biochemical monitoring.
The content published in this section of the website is intended for informational and educational purposes only and is addressed to both healthcare professionals and the general public. While prepared with care and based on scientific evidence and guidelines available at the time of publication, the texts may contain errors, inaccuracies, or information that is not up to date with the most recent developments in the medical and scientific literature.
The content does not constitute medical advice, diagnosis, or treatment recommendations of any kind and does not replace the direct relationship between a patient and their treating physician. Meditalia S.r.l. accepts no liability for clinical decisions made on the basis of the information provided herein.
For any concerns regarding health conditions, diagnostic procedures, or treatments, please always consult a qualified physician or healthcare professional. To report possible inaccuracies in the content, please contact Meditalia S.r.l. through the channels listed in the Contacts section of the website.
Please enter the required details to get in touch with your local Meditalia representative.
Meditalia S.r.l.
Meditalia Blog
20/07/2026
14/07/2026